See every facility — official ratings, family reviews, no referral fees.
Nursing HomeMedicaid

South Mountain Post Acute

8008 S. Jesse Owens Parkway, Phoenix, AZ 85042Licensed & Active

Limited public data available for this facility. Call to verify details directly.

Watch South Mountain Post Acute

Get an email when new inspections, ratings, or penalties are published for this facility.

We’ll only email you about this — no spam, unsubscribe anytime.

Nearby Alternatives To Compare

Compare this facility with at least one nearby backup option.

When public data is thin, nearby alternatives give you better context on pricing, reviews, and how much information is publicly available in the same market.

Verify sources first

Inspection History

State Inspection History

State Inspections

Source: AZ State Licensing Agency

22total
13deficiencies
Mar 3, 2026Complaint
CleanReport

A complaint survey was conducted on March 3, 2026 for the investigation of intake(s) # 00158662, 00156850, 00155375, 00156103. There were no findings cited.

Sep 24, 2025Complaint
CleanReport

A complaint investigation was conducted on September 24, 2025,  of intake #00144945. There were no deficiencies.

Jul 21, 2025Complaint

The investigation of complaints 2564650, 00136792, 2561015, 00136389, 2566916, 2567043, and 00136973 was conducted on July 21, 2025, The following deficiencies were cited.

21(b)(3) Comprehensive Care Plans The services provided or arranged by the facility, as outlined by the comprehensive care plan, must- (i) Meet professional standards of quality.Services Provided Meet Professional Standards - 0658 FederalCorrected Aug 14, 2025

The facility failed to ensure proper monitoring for 1 out of 3 dialysis residents (#1).

An administrator shall ensure that a care plan for a resident: R9-10-414.B.3. Ensures that a resident is provided nursing care institution services that: R9-10-414.B.3.b. Assist the resident in R9-10-414.B.3.b.Corrected Aug 14, 2025

The facility failed to ensure proper monitoring for 1 out of 3 dialysis residents (#1).

Jul 11, 2025Complaint
CleanReport

A Complaint survey #1D0E54-H1was performed on July 11 and 14, 2025.Investigation of Complaints 00135971 and 00136174 was conducted via closed record review, observation of current facility practice, staff interviews and review of facility documentation.No Deficiencies were cited.

Jun 5, 2025Complaint
CleanReport

A complaint survey was conducted on June 5, 2025 for the investigation of intake #SF00131430. There were no deficiencies cited.

Jan 17, 2025Complaint
CleanReport

A complaint investigation was conducted on January 17, 2025 through January 22, 2025 of intake # AZ00221986, AZ00221886, AZ00221890. There were no citations cited.

Jan 6, 2025Complaint
CleanReport

The complaint survey was conducted on January 06, 2025 of the following complaint #'s AZ00221387, AZ00221291, AZ00221275. There were no deficiencies cited.

Dec 16, 2024Complaint

The investigation of Complaint AZ00220300, AZ00219780, AZ00220102, AZ00220188 was conducted on 12/16/2024 through 12/18/2024. The following deficiencies were cited:

21(b)(3) Comprehensive Care Plans The services provided or arranged by the facility, as outlined by the comprehensive care plan, must- (i) Meet professional standards of quality.483.21(b)(3)(i) FederalCorrected Dec 30, 2024

Based on clinical record review, staff interviews and policy reviews, the facility failed to ensure that 1 of 3 sampled residents (#2) received long-acting insulin per hospital discharge orders upon admission. The deficient practice could result in uncontrolled blood sugar levels. Findings include: Resident #2 was admitted on February 13, 2024 with diagnoses that included type 2 diabetes mellitus, Parkinson's disease, and dementia. Review of final orders/discharge instructions from the referring hospital, dated February 13, 2024 (prior to admission), included that the patient was to continue insulin Glargine (insulin glargine/Lantus) 15 units twice daily without any changes. Review of physician's orders dated February 13th- 19th,2024 revealed no evidence of physician orders regarding Insulin Glargine despite being listed on the hospital final orders/discharge instructions. An order summery dated February 13, 2024 revealed all medication orders were reviewed by the attending physician and he concurred with the present plan of care and discharge plan. Further review of physician orders dated February 14, 2024 included Glucose monitoring with instructions to notify the provider if glucose is less than 70 or more than 400 mg/dL. A Care Plan dated February 14, 2024, revealed a focus of Diabetes Mellitus with interventions that included diabetes medication as ordered by doctor, monitor/document for side effects and effectiveness, monitor/document/report to MD PRN (as needed) signs and symptoms of hyperglycemia. An Admission MDS (Minimum Data Set) assessment dated February 17, 2024 included that the resident had a BIMS (Brief Interview for Mental Status) score of 2, which indicated severe cognitive impairment. The assessment indicated the resident had clear speech, was not oriented to time or place and at times appeared anxious, fearful and wandered. On February 18, 2024 the resident's blood glucose test results were 572.0 mg/dL. A progress note dated February 18, 2024 revealed that the resident's blood sugar was 572.0 mg/dL at 1:06pm and the provider was notified. However, there was no evidence regarding the provider's response including any medication changes, related to the increase in blood glucose levels. On February 18, 2024 at 4:41pm, the resident's blood glucose level was 219.0 mg/dL. A nursing progress note dated February 18, 2024 revealed blood glucose level at baseline and well controlled, despite evidence of blood glucose fluctuations during the day. A review of the resident's blood glucose results on February 19 through February 20, 2024 revealed: February 19, 2024 - 8:32 am- 229.0 mg/dL - 11:37 am- 271.0 mg/dL - 5:01 pm- 333.0 mg/dL - 10:03 pm- 321.0 mg/dL February 20, 2024 - 8:03 am- 337.0 mg/dL - 8:33 am- 337.0 mg/dL - 12:03 pm-337.0 mg/dL - 4:45 pm -357.0 mg/dL - 7:08 pm- 335.0 mg/dL A FNP (Family Nurse Practitioner) progress note dated February 20, 2024 indicated that, the resident's blood glucose remains elevated and to start a low do

An administrator shall ensure that a care plan for a resident: R9-10-414.B.3. Ensures that a resident is provided nursing care institution services that: R9-10-414.B.3.b. Assist the resident in R9-10-414.B.3.b.Corrected Dec 30, 2024

Based on clinical record review, staff interviews and policy reviews, the facility failed to ensure that 1 of 3 sampled residents (#2) received long-acting insulin per hospital discharge orders upon admission. Findings include: Resident #2 was admitted on February 13, 2024 with diagnoses that included type 2 diabetes mellitus, Parkinson's disease, and dementia. Review of final orders/discharge instructions from the referring hospital, dated February 13, 2024 (prior to admission), included that the patient was to continue insulin Glargine (insulin glargine/Lantus) 15 units twice daily without any changes. Review of physician's orders dated February 13th- 19th,2024 revealed no evidence of physician orders regarding Insulin Glargine despite being listed on the hospital final orders/discharge instructions. An order summery dated February 13, 2024 revealed all medication orders were reviewed by the attending physician and he concurred with the present plan of care and discharge plan. Further review of physician orders dated February 14, 2024 included Glucose monitoring with instructions to notify the provider if glucose is less than 70 or more than 400 mg/dL. A Care Plan dated February 14, 2024, revealed a focus of Diabetes Mellitus with interventions that included diabetes medication as ordered by doctor, monitor/document for side effects and effectiveness, monitor/document/report to MD PRN (as needed) signs and symptoms of hyperglycemia. An Admission MDS (Minimum Data Set) assessment dated February 17, 2024 included that the resident had a BIMS (Brief Interview for Mental Status) score of 2, which indicated severe cognitive impairment. The assessment indicated the resident had clear speech, was not oriented to time or place and at times appeared anxious, fearful and wandered. On February 18, 2024 the resident's blood glucose test results were 572.0 mg/dL. A progress note dated February 18, 2024 revealed that the resident's blood sugar was 572.0 mg/dL at 1:06pm and the provider was notified. However, there was no evidence regarding the provider's response including any medication changes, related to the increase in blood glucose levels. On February 18, 2024 at 4:41pm, the resident's blood glucose level was 219.0 mg/dL. A nursing progress note dated February 18, 2024 revealed blood glucose level at baseline and well controlled, despite evidence of blood glucose fluctuations during the day. A review of the resident's blood glucose results on February 19 through February 20, 2024 revealed: February 19, 2024 - 8:32 am- 229.0 mg/dL - 11:37 am- 271.0 mg/dL - 5:01 pm- 333.0 mg/dL - 10:03 pm- 321.0 mg/dL February 20, 2024 - 8:03 am- 337.0 mg/dL - 8:33 am- 337.0 mg/dL - 12:03 pm-337.0 mg/dL - 4:45 pm -357.0 mg/dL - 7:08 pm- 335.0 mg/dL A FNP (Family Nurse Practitioner) progress note dated February 20, 2024 indicated that, the resident's blood glucose remains elevated and to start a low dose of Glargine/Lantus 5 units at bed time. A Physician Order dated, Febr

Contact

Get in Touch

Contact this facility directly and verify the details that matter most to your family.

References & Resources

EveryPlace is a research directory. Facility information is compiled from public sources — Medicare.gov, state licensing portals, Google Places, and publicly available street-level imagery. Listings do not constitute endorsement, recommendation, or advertisement, and we do not accept payment for placement. Families should verify all details directly with the facility and the original sources linked above before making any care decisions. See our Research Policy for our editorial standards, correction process, and image-removal policy.

Call